Skip to content
lifestyle.bossesmag.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Oculis Holding AG
Latest Findings from DME AWARE Delphi Study Presented at ARVO 2026 Annual Meeting
May 28, 2026
Oculis to Present at Upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
May 27, 2026
Oculis Publishes Invitation to the Annual General Meeting
May 26, 2026
Oculis Announces Completion of Last Patient Visit in Phase 3 DIAMOND Program with OCS-01 Eye Drops for the Treatment of Diabetic Macular Edema
May 25, 2026
Oculis to Participate in Upcoming Investor Conferences
May 24, 2026
Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential First‑in‑Class Neuroprotective Candidate for Optic Neuritis
May 22, 2026
Oculis to Present at Upcoming North American Neuro-Ophthalmology Society Annual Meeting
May 20, 2026
Oculis to Participate in Upcoming Investor Conferences
May 16, 2026
Oculis Reports Q4 and Full Year 2025 Financial Results and Provides Company Update
May 16, 2026